LAMEA Huntington's Disease Treatment Market Size, Share & Trends Analysis Report By Drug Type (Approved Drugs (Tetrabenazine and Deutetrabenazine) and Offlabel Drugs), By Distribution Channel, By Age, By Country and Growth Forecast, 2024

List of Tables

The Latin America, Middle East and Africa Huntington's Disease Treatment Market would witness market growth of 10.8% CAGR during the forecast period (2024-2031).

The Brazil market dominated the LAMEA Huntington's Disease Treatment Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $15,703.9 Thousands by 2031. The Argentina market is showcasing a CAGR of 11.6% during (2024 - 2031). Additionally, The UAE market would register a CAGR of 10.4% during (2024 - 2031).

Various factors, including clinical efficacy, safety profiles, regulatory approvals, healthcare infrastructure, patient and caregiver education, and the availability of supportive services, influence the adoption of treatments for Huntington's Disease (HD). Healthcare providers prioritize treatments that demonstrate efficacy in managing HD symptoms and improving patient outcomes. Therapies that effectively control chorea, dystonia, psychiatric symptoms, and cognitive decline are crucial for adoption.

Also, access to specialized HD clinics and neurology expertise influences treatment adoption. Healthcare facilities equipped to provide comprehensive care, including multidisciplinary teams and supportive services, enhance the delivery and adoption of HD treatments. Education programs are essential for adoption because they provide patients and carers with information about HD, accessible therapies, and helpful resources. Understanding treatment options, potential benefits, and risks facilitates informed decision-making and engagement in care.

With increased funding, Saudi Arabia can expand and modernize its healthcare infrastructure to include specialized neurology clinics and centers of excellence for HD diagnosis, treatment, and research. This expansion improves access to comprehensive care for HD patients across different kingdom regions. According to the ITA, Saudi Arabia contributes 60% of the healthcare expenditures of the Gulf Cooperation Council (GCC) nations, and the Saudi Arabian government continues to prioritize this sector. It was projected to spend $50.4 billion on healthcare and social development in 2023, representing 16.96 percent of its budget and ranking second only to education in terms of expenditure. Thus, the rising healthcare budget in the region is propelling the market's growth.

Based on Drug Type, the market is segmented into Approved Drugs (Tetrabenazine and Deutetrabenazine) and Offlabel Drugs. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Drug Store & Retail Pharmacies, and Online Pharmacies. Based on Age, the market is segmented into Below 50 years and Above 50 years. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

List of Key Companies Profiled

Bausch Health Companies, Inc.
Teva Pharmaceutical Industries Ltd.
Camber Pharmaceuticals, Inc. (Hetero Labs Limited)
Hikma Pharmaceuticals PLC
Takeda Pharmaceutical Company Limited
Sun Pharmaceutical Industries Ltd.
Dr. Reddy's Laboratories Ltd.
Neurocrine Biosciences Inc.
Pfizer, Inc.
F. Hoffmann-La Roche Ltd.

LAMEA Huntington's Disease Treatment Market Report Segmentation

By Drug Type

Approved Drugs
- Tetrabenazine
- Deutetrabenazine
Offlabel Drugs

By Distribution Channel

Hospital Pharmacies
Drug Store & Retail Pharmacies
Online Pharmacies

By Age

Below 50 years
Above 50 years

By Country

Brazil
Argentina
UAE
Saudi Arabia
South Africa
Nigeria
Rest of LAMEA

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 LAMEA Huntington's Disease Treatment Market, by Drug Type
- 1.4.2 LAMEA Huntington's Disease Treatment Market, by Distribution Channel
- 1.4.3 LAMEA Huntington's Disease Treatment Market, by Age
- 1.4.4 LAMEA Huntington's Disease Treatment Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance

2.1 Key Highlights

Chapter 3. Market Overview

3.1 Introduction
- 3.1.1 Overview
  - 3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. LAMEA Huntington's Disease Treatment Market by Drug Type

4.1 LAMEA Approved Drugs Market by Country
4.2 LAMEA Huntington's Disease Treatment Market by Approved Drugs Type
- 4.2.1 LAMEA Tetrabenazine Market by Country
- 4.2.2 LAMEA Deutetrabenazine Market by Country
4.3 LAMEA Offlabel Drugs Market by Country

Chapter 5. LAMEA Huntington's Disease Treatment Market by Distribution Channel

5.1 LAMEA Hospital Pharmacies Market by Country
5.2 LAMEA Drug Store & Retail Pharmacies Market by Country
5.3 LAMEA Online Pharmacies Market by Country

Chapter 6. LAMEA Huntington's Disease Treatment Market by Age

6.1 LAMEA Below 50 years Market by Country
6.2 LAMEA Above 50 years Market by Country

Chapter 7. LAMEA Huntington's Disease Treatment Market by Country

7.1 Brazil Huntington's Disease Treatment Market
- 7.1.1 Brazil Huntington's Disease Treatment Market by Drug Type
  - 7.1.1.1 Brazil Huntington's Disease Treatment Market by Approved Drugs Type
- 7.1.2 Brazil Huntington's Disease Treatment Market by Distribution Channel
- 7.1.3 Brazil Huntington's Disease Treatment Market by Age
7.2 Argentina Huntington's Disease Treatment Market
- 7.2.1 Argentina Huntington's Disease Treatment Market by Drug Type
  - 7.2.1.1 Argentina Huntington's Disease Treatment Market by Approved Drugs Type
- 7.2.2 Argentina Huntington's Disease Treatment Market by Distribution Channel
- 7.2.3 Argentina Huntington's Disease Treatment Market by Age
7.3 UAE Huntington's Disease Treatment Market
- 7.3.1 UAE Huntington's Disease Treatment Market by Drug Type
  - 7.3.1.1 UAE Huntington's Disease Treatment Market by Approved Drugs Type
- 7.3.2 UAE Huntington's Disease Treatment Market by Distribution Channel
- 7.3.3 UAE Huntington's Disease Treatment Market by Age
7.4 Saudi Arabia Huntington's Disease Treatment Market
- 7.4.1 Saudi Arabia Huntington's Disease Treatment Market by Drug Type
  - 7.4.1.1 Saudi Arabia Huntington's Disease Treatment Market by Approved Drugs Type
- 7.4.2 Saudi Arabia Huntington's Disease Treatment Market by Distribution Channel
- 7.4.3 Saudi Arabia Huntington's Disease Treatment Market by Age
7.5 South Africa Huntington's Disease Treatment Market
- 7.5.1 South Africa Huntington's Disease Treatment Market by Drug Type
  - 7.5.1.1 South Africa Huntington's Disease Treatment Market by Approved Drugs Type
- 7.5.2 South Africa Huntington's Disease Treatment Market by Distribution Channel
- 7.5.3 South Africa Huntington's Disease Treatment Market by Age
7.6 Nigeria Huntington's Disease Treatment Market
- 7.6.1 Nigeria Huntington's Disease Treatment Market by Drug Type
  - 7.6.1.1 Nigeria Huntington's Disease Treatment Market by Approved Drugs Type
- 7.6.2 Nigeria Huntington's Disease Treatment Market by Distribution Channel
- 7.6.3 Nigeria Huntington's Disease Treatment Market by Age
7.7 Rest of LAMEA Huntington's Disease Treatment Market
- 7.7.1 Rest of LAMEA Huntington's Disease Treatment Market by Drug Type
  - 7.7.1.1 Rest of LAMEA Huntington's Disease Treatment Market by Approved Drugs Type
- 7.7.2 Rest of LAMEA Huntington's Disease Treatment Market by Distribution Channel
- 7.7.3 Rest of LAMEA Huntington's Disease Treatment Market by Age

Chapter 8. Company Profiles

8.1 Dr. Reddy's Laboratories Ltd.
- 8.1.1 Company Overview
- 8.1.2 Financial Analysis
- 8.1.3 Segmental and Regional Analysis
- 8.1.4 Research & Development Expense
- 8.1.5 SWOT Analysis
8.2 Takeda Pharmaceutical Company Limited
- 8.2.1 Company Overview
- 8.2.2 Financial Analysis
- 8.2.3 Regional Analysis
- 8.2.4 Research & Development Expense
- 8.2.5 SWOT Analysis
8.3 Sun Pharmaceutical Industries Ltd.
- 8.3.1 Company Overview
- 8.3.2 Financial Analysis
- 8.3.3 Regional Analysis
- 8.3.4 Research & Development Expenses
- 8.3.5 SWOT Analysis
8.4 Hikma Pharmaceuticals PLC
- 8.4.1 Company Overview
- 8.4.2 Financial Analysis
- 8.4.3 Segmental and Regional Analysis
- 8.4.4 Research & Development Expenses
8.5 Camber Pharmaceuticals, Inc. (Hetero Labs Limited)
- 8.5.1 Company Overview
8.6 Teva Pharmaceutical Industries Ltd.
- 8.6.1 Company Overview
- 8.6.2 Financial Analysis
- 8.6.3 Regional Analysis
- 8.6.4 Research & Development Expenses
- 8.6.5 SWOT Analysis
8.7 Bausch Health Companies, Inc
- 8.7.1 Company Overview
- 8.7.2 Financial Analysis
- 8.7.3 Segmental and Regional Analysis
- 8.7.4 Research & Development Expense
- 8.7.5 SWOT Analysis
8.8 Neurocrine Biosciences Inc.
- 8.8.1 Company Overview
- 8.8.2 Financial Analysis
- 8.8.3 Research & Development Expenses
8.9 Pfizer, Inc.
- 8.9.1 Company Overview
- 8.9.2 Financial Analysis
- 8.9.3 Regional & Segmental Analysis
- 8.9.4 Research & Development Expense
- 8.9.5 SWOT Analysis
8.10. F. Hoffmann-La Roche Ltd.
- 8.10.1 Company Overview
- 8.10.2 Financial Analysis
- 8.10.3 Segmental and Regional Analysis
- 8.10.4 Research & Development Expense
- 8.10.5 SWOT Analysis

LIST OF TABLES

TABLE 1 LAMEA Huntington's Disease Treatment Market, 2020 - 2023, USD Thousands
TABLE 2 LAMEA Huntington's Disease Treatment Market, 2024 - 2031, USD Thousands
TABLE 3 LAMEA Huntington's Disease Treatment Market by Drug Type, 2020 - 2023, USD Thousands
TABLE 4 LAMEA Huntington's Disease Treatment Market by Drug Type, 2024 - 2031, USD Thousands
TABLE 5 LAMEA Approved Drugs Market by Country, 2020 - 2023, USD Thousands
TABLE 6 LAMEA Approved Drugs Market by Country, 2024 - 2031, USD Thousands
TABLE 7 LAMEA Huntington's Disease Treatment Market by Approved Drugs Type, 2020 - 2023, USD Thousands
TABLE 8 LAMEA Huntington's Disease Treatment Market by Approved Drugs Type, 2024 - 2031, USD Thousands
TABLE 9 LAMEA Tetrabenazine Market by Country, 2020 - 2023, USD Thousands
TABLE 10 LAMEA Tetrabenazine Market by Country, 2024 - 2031, USD Thousands
TABLE 11 LAMEA Deutetrabenazine Market by Country, 2020 - 2023, USD Thousands
TABLE 12 LAMEA Deutetrabenazine Market by Country, 2024 - 2031, USD Thousands
TABLE 13 LAMEA Offlabel Drugs Market by Country, 2020 - 2023, USD Thousands
TABLE 14 LAMEA Offlabel Drugs Market by Country, 2024 - 2031, USD Thousands
TABLE 15 LAMEA Huntington's Disease Treatment Market by Distribution Channel, 2020 - 2023, USD Thousands
TABLE 16 LAMEA Huntington's Disease Treatment Market by Distribution Channel, 2024 - 2031, USD Thousands
TABLE 17 LAMEA Hospital Pharmacies Market by Country, 2020 - 2023, USD Thousands
TABLE 18 LAMEA Hospital Pharmacies Market by Country, 2024 - 2031, USD Thousands
TABLE 19 LAMEA Drug Store & Retail Pharmacies Market by Country, 2020 - 2023, USD Thousands
TABLE 20 LAMEA Drug Store & Retail Pharmacies Market by Country, 2024 - 2031, USD Thousands
TABLE 21 LAMEA Online Pharmacies Market by Country, 2020 - 2023, USD Thousands
TABLE 22 LAMEA Online Pharmacies Market by Country, 2024 - 2031, USD Thousands
TABLE 23 LAMEA Huntington's Disease Treatment Market by Age, 2020 - 2023, USD Thousands
TABLE 24 LAMEA Huntington's Disease Treatment Market by Age, 2024 - 2031, USD Thousands
TABLE 25 LAMEA Below 50 years Market by Country, 2020 - 2023, USD Thousands
TABLE 26 LAMEA Below 50 years Market by Country, 2024 - 2031, USD Thousands
TABLE 27 LAMEA Above 50 years Market by Country, 2020 - 2023, USD Thousands
TABLE 28 LAMEA Above 50 years Market by Country, 2024 - 2031, USD Thousands
TABLE 29 LAMEA Huntington's Disease Treatment Market by Country, 2020 - 2023, USD Thousands
TABLE 30 LAMEA Huntington's Disease Treatment Market by Country, 2024 - 2031, USD Thousands
TABLE 31 Brazil Huntington's Disease Treatment Market, 2020 - 2023, USD Thousands
TABLE 32 Brazil Huntington's Disease Treatment Market, 2024 - 2031, USD Thousands
TABLE 33 Brazil Huntington's Disease Treatment Market by Drug Type, 2020 - 2023, USD Thousands
TABLE 34 Brazil Huntington's Disease Treatment Market by Drug Type, 2024 - 2031, USD Thousands
TABLE 35 Brazil Huntington's Disease Treatment Market by Approved Drugs Type, 2020 - 2023, USD Thousands
TABLE 36 Brazil Huntington's Disease Treatment Market by Approved Drugs Type, 2024 - 2031, USD Thousands
TABLE 37 Brazil Huntington's Disease Treatment Market by Distribution Channel, 2020 - 2023, USD Thousands
TABLE 38 Brazil Huntington's Disease Treatment Market by Distribution Channel, 2024 - 2031, USD Thousands
TABLE 39 Brazil Huntington's Disease Treatment Market by Age, 2020 - 2023, USD Thousands
TABLE 40 Brazil Huntington's Disease Treatment Market by Age, 2024 - 2031, USD Thousands
TABLE 41 Argentina Huntington's Disease Treatment Market, 2020 - 2023, USD Thousands
TABLE 42 Argentina Huntington's Disease Treatment Market, 2024 - 2031, USD Thousands
TABLE 43 Argentina Huntington's Disease Treatment Market by Drug Type, 2020 - 2023, USD Thousands
TABLE 44 Argentina Huntington's Disease Treatment Market by Drug Type, 2024 - 2031, USD Thousands
TABLE 45 Argentina Huntington's Disease Treatment Market by Approved Drugs Type, 2020 - 2023, USD Thousands
TABLE 46 Argentina Huntington's Disease Treatment Market by Approved Drugs Type, 2024 - 2031, USD Thousands
TABLE 47 Argentina Huntington's Disease Treatment Market by Distribution Channel, 2020 - 2023, USD Thousands
TABLE 48 Argentina Huntington's Disease Treatment Market by Distribution Channel, 2024 - 2031, USD Thousands
TABLE 49 Argentina Huntington's Disease Treatment Market by Age, 2020 - 2023, USD Thousands
TABLE 50 Argentina Huntington's Disease Treatment Market by Age, 2024 - 2031, USD Thousands
TABLE 51 UAE Huntington's Disease Treatment Market, 2020 - 2023, USD Thousands
TABLE 52 UAE Huntington's Disease Treatment Market, 2024 - 2031, USD Thousands
TABLE 53 UAE Huntington's Disease Treatment Market by Drug Type, 2020 - 2023, USD Thousands
TABLE 54 UAE Huntington's Disease Treatment Market by Drug Type, 2024 - 2031, USD Thousands
TABLE 55 UAE Huntington's Disease Treatment Market by Approved Drugs Type, 2020 - 2023, USD Thousands
TABLE 56 UAE Huntington's Disease Treatment Market by Approved Drugs Type, 2024 - 2031, USD Thousands
TABLE 57 UAE Huntington's Disease Treatment Market by Distribution Channel, 2020 - 2023, USD Thousands
TABLE 58 UAE Huntington's Disease Treatment Market by Distribution Channel, 2024 - 2031, USD Thousands
TABLE 59 UAE Huntington's Disease Treatment Market by Age, 2020 - 2023, USD Thousands
TABLE 60 UAE Huntington's Disease Treatment Market by Age, 2024 - 2031, USD Thousands
TABLE 61 Saudi Arabia Huntington's Disease Treatment Market, 2020 - 2023, USD Thousands
TABLE 62 Saudi Arabia Huntington's Disease Treatment Market, 2024 - 2031, USD Thousands
TABLE 63 Saudi Arabia Huntington's Disease Treatment Market by Drug Type, 2020 - 2023, USD Thousands
TABLE 64 Saudi Arabia Huntington's Disease Treatment Market by Drug Type, 2024 - 2031, USD Thousands
TABLE 65 Saudi Arabia Huntington's Disease Treatment Market by Approved Drugs Type, 2020 - 2023, USD Thousands
TABLE 66 Saudi Arabia Huntington's Disease Treatment Market by Approved Drugs Type, 2024 - 2031, USD Thousands
TABLE 67 Saudi Arabia Huntington's Disease Treatment Market by Distribution Channel, 2020 - 2023, USD Thousands
TABLE 68 Saudi Arabia Huntington's Disease Treatment Market by Distribution Channel, 2024 - 2031, USD Thousands
TABLE 69 Saudi Arabia Huntington's Disease Treatment Market by Age, 2020 - 2023, USD Thousands
TABLE 70 Saudi Arabia Huntington's Disease Treatment Market by Age, 2024 - 2031, USD Thousands
TABLE 71 South Africa Huntington's Disease Treatment Market, 2020 - 2023, USD Thousands
TABLE 72 South Africa Huntington's Disease Treatment Market, 2024 - 2031, USD Thousands
TABLE 73 South Africa Huntington's Disease Treatment Market by Drug Type, 2020 - 2023, USD Thousands
TABLE 74 South Africa Huntington's Disease Treatment Market by Drug Type, 2024 - 2031, USD Thousands
TABLE 75 South Africa Huntington's Disease Treatment Market by Approved Drugs Type, 2020 - 2023, USD Thousands
TABLE 76 South Africa Huntington's Disease Treatment Market by Approved Drugs Type, 2024 - 2031, USD Thousands
TABLE 77 South Africa Huntington's Disease Treatment Market by Distribution Channel, 2020 - 2023, USD Thousands
TABLE 78 South Africa Huntington's Disease Treatment Market by Distribution Channel, 2024 - 2031, USD Thousands
TABLE 79 South Africa Huntington's Disease Treatment Market by Age, 2020 - 2023, USD Thousands
TABLE 80 South Africa Huntington's Disease Treatment Market by Age, 2024 - 2031, USD Thousands
TABLE 81 Nigeria Huntington's Disease Treatment Market, 2020 - 2023, USD Thousands
TABLE 82 Nigeria Huntington's Disease Treatment Market, 2024 - 2031, USD Thousands
TABLE 83 Nigeria Huntington's Disease Treatment Market by Drug Type, 2020 - 2023, USD Thousands
TABLE 84 Nigeria Huntington's Disease Treatment Market by Drug Type, 2024 - 2031, USD Thousands
TABLE 85 Nigeria Huntington's Disease Treatment Market by Approved Drugs Type, 2020 - 2023, USD Thousands
TABLE 86 Nigeria Huntington's Disease Treatment Market by Approved Drugs Type, 2024 - 2031, USD Thousands
TABLE 87 Nigeria Huntington's Disease Treatment Market by Distribution Channel, 2020 - 2023, USD Thousands
TABLE 88 Nigeria Huntington's Disease Treatment Market by Distribution Channel, 2024 - 2031, USD Thousands
TABLE 89 Nigeria Huntington's Disease Treatment Market by Age, 2020 - 2023, USD Thousands
TABLE 90 Nigeria Huntington's Disease Treatment Market by Age, 2024 - 2031, USD Thousands
TABLE 91 Rest of LAMEA Huntington's Disease Treatment Market, 2020 - 2023, USD Thousands
TABLE 92 Rest of LAMEA Huntington's Disease Treatment Market, 2024 - 2031, USD Thousands
TABLE 93 Rest of LAMEA Huntington's Disease Treatment Market by Drug Type, 2020 - 2023, USD Thousands
TABLE 94 Rest of LAMEA Huntington's Disease Treatment Market by Drug Type, 2024 - 2031, USD Thousands
TABLE 95 Rest of LAMEA Huntington's Disease Treatment Market by Approved Drugs Type, 2020 - 2023, USD Thousands
TABLE 96 Rest of LAMEA Huntington's Disease Treatment Market by Approved Drugs Type, 2024 - 2031, USD Thousands
TABLE 97 Rest of LAMEA Huntington's Disease Treatment Market by Distribution Channel, 2020 - 2023, USD Thousands
TABLE 98 Rest of LAMEA Huntington's Disease Treatment Market by Distribution Channel, 2024 - 2031, USD Thousands
TABLE 99 Rest of LAMEA Huntington's Disease Treatment Market by Age, 2020 - 2023, USD Thousands
TABLE 100 Rest of LAMEA Huntington's Disease Treatment Market by Age, 2024 - 2031, USD Thousands
TABLE 101 Key Information - Dr. Reddy's Laboratories Ltd.
TABLE 102 Key Information - Takeda Pharmaceutical Company Limited
TABLE 103 Key Information - Sun Pharmaceutical Industries Ltd.
TABLE 104 Key Information - Hikma Pharmaceuticals PLC
TABLE 105 Key Information - Camber Pharmaceuticals, Inc.
TABLE 106 Key Information - Teva Pharmaceuticals Industries Ltd.
TABLE 107 key information - Bausch Health Companies, Inc.
TABLE 108 Key Information - Neurocrine Biosciences Inc.
TABLE 109 Key Information - Pfizer, Inc.
TABLE 110 Key Information - F. Hoffmann-La Roche Ltd.

LAMEA Huntington's Disease Treatment Market Size, Share & Trends Analysis Report By Drug Type (Approved Drugs (Tetrabenazine and Deutetrabenazine) and Offlabel Drugs), By Distribution Channel, By Age, By Country and Growth Forecast, 2024 - 2031

Description

Table of Contents